Genky DrugStores Co., Ltd. (9267.T)
JPY 3190.0
(1.11%)
JPY 3190.0
(1.11%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 14.47 Billion JPY | 20.47% |
| 2022 | 11.72 Billion JPY | 12.99% |
| 2021 | 10.73 Billion JPY | -0.03% |
| 2020 | 10.77 Billion JPY | 27.73% |
| 2019 | 7.85 Billion JPY | 9.31% |
| 2018 | 7.25 Billion JPY | 4.73% |
| 2017 | 7.28 Billion JPY | 8.3% |
| 2016 | 6.76 Billion JPY | 31.57% |
| 2015 | 5.12 Billion JPY | 14.35% |
| 2014 | 4.46 Billion JPY | 27.38% |
| 2013 | 3.51 Billion JPY | 43.4% |
| 2012 | 2.43 Billion JPY | -25.43% |
| 2011 | 3.27 Billion JPY | 17.37% |
| 2010 | 2.69 Billion JPY | 30.57% |
| 2009 | 2.08 Billion JPY | 17.66% |
| 2008 | 1.77 Billion JPY | 2.86% |
| 2007 | 1.78 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 3.8 Billion JPY | -1.73% |
| 2023 Q3 | 2.1 Billion JPY | -13.39% |
| 2023 FY | - JPY | 20.47% |
| 2023 Q2 | 2.43 Billion JPY | 15.79% |
| 2023 Q1 | 2.1 Billion JPY | 2.09% |
| 2023 Q4 | 4.01 Billion JPY | 90.47% |
| 2022 Q2 | 1.89 Billion JPY | 11.92% |
| 2022 Q3 | 1.49 Billion JPY | -21.09% |
| 2022 Q4 | 2.06 Billion JPY | 37.61% |
| 2022 Q1 | 1.69 Billion JPY | 5.59% |
| 2022 FY | - JPY | 12.99% |
| 2021 Q3 | 1.36 Billion JPY | 3.23% |
| 2021 FY | - JPY | -0.03% |
| 2021 Q1 | 1.83 Billion JPY | 4.17% |
| 2021 Q2 | 1.31 Billion JPY | -28.02% |
| 2021 Q4 | 1.6 Billion JPY | 17.82% |
| 2020 Q4 | 1.76 Billion JPY | 21.48% |
| 2020 Q3 | 1.44 Billion JPY | -14.32% |
| 2020 Q2 | 1.69 Billion JPY | -6.72% |
| 2020 Q1 | 1.81 Billion JPY | -5.57% |
| 2020 FY | - JPY | 27.73% |
| 2019 Q2 | 406.58 Million JPY | -42.38% |
| 2019 Q4 | 1.91 Billion JPY | 33.9% |
| 2019 FY | - JPY | 9.31% |
| 2019 Q1 | 705.59 Million JPY | -10.09% |
| 2019 Q3 | 1.43 Billion JPY | 252.63% |
| 2018 Q3 | 987.87 Million JPY | 5.5% |
| 2018 Q4 | 784.77 Million JPY | -20.56% |
| 2018 FY | - JPY | 4.73% |
| 2018 Q1 | 1.22 Billion JPY | -11.61% |
| 2018 Q2 | 936.36 Million JPY | -23.66% |
| 2017 Q1 | 1.14 Billion JPY | -15.2% |
| 2017 Q4 | 1.38 Billion JPY | 54.4% |
| 2017 Q3 | 898.72 Million JPY | -5.37% |
| 2017 FY | - JPY | 8.3% |
| 2017 Q2 | 949.77 Million JPY | -17.39% |
| 2016 Q4 | 1.35 Billion JPY | 86.35% |
| 2016 Q1 | 1.13 Billion JPY | 3.24% |
| 2016 Q2 | 935.04 Million JPY | -17.5% |
| 2016 Q3 | 727.6 Million JPY | -22.18% |
| 2016 FY | - JPY | 31.57% |
| 2015 FY | - JPY | 14.35% |
| 2015 Q4 | 1.09 Billion JPY | 98.34% |
| 2015 Q3 | 553.55 Million JPY | -9.98% |
| 2015 Q2 | 614.91 Million JPY | -10.47% |
| 2015 Q1 | 686.83 Million JPY | -22.39% |
| 2014 Q4 | 885.01 Million JPY | 21.07% |
| 2014 FY | - JPY | 27.38% |
| 2014 Q1 | 724.64 Million JPY | -23.45% |
| 2014 Q2 | 609.09 Million JPY | -15.95% |
| 2014 Q3 | 730.99 Million JPY | 20.01% |
| 2013 FY | - JPY | 43.4% |
| 2013 Q2 | 353.3 Million JPY | 10.73% |
| 2013 Q3 | 444.14 Million JPY | 25.71% |
| 2013 Q4 | 946.66 Million JPY | 113.14% |
| 2013 Q1 | 319.07 Million JPY | -40.51% |
| 2012 FY | - JPY | -25.43% |
| 2012 Q2 | 80.41 Million JPY | -73.11% |
| 2012 Q4 | 536.36 Million JPY | 219.43% |
| 2012 Q1 | 299.02 Million JPY | -55.73% |
| 2012 Q3 | 167.91 Million JPY | 108.82% |
| 2011 Q4 | 675.51 Million JPY | 40.85% |
| 2011 Q3 | 479.57 Million JPY | -4.7% |
| 2011 Q2 | 503.22 Million JPY | 7.01% |
| 2011 Q1 | 470.26 Million JPY | -39.2% |
| 2011 FY | - JPY | 17.37% |
| 2010 Q2 | 534.55 Million JPY | -22.92% |
| 2010 Q3 | 811.53 Million JPY | 51.81% |
| 2010 FY | - JPY | 30.57% |
| 2010 Q1 | 693.48 Million JPY | 16.86% |
| 2010 Q4 | 773.49 Million JPY | -4.69% |
| 2009 Q2 | 489.56 Million JPY | -20.78% |
| 2009 FY | - JPY | 17.66% |
| 2009 Q4 | 593.43 Million JPY | 30.86% |
| 2009 Q1 | 617.97 Million JPY | 11.98% |
| 2009 Q3 | 453.47 Million JPY | -7.37% |
| 2008 Q3 | 422.97 Million JPY | -10.47% |
| 2008 Q2 | 472.46 Million JPY | 23.1% |
| 2008 Q1 | 383.81 Million JPY | 0.0% |
| 2008 FY | - JPY | 2.86% |
| 2008 Q4 | 551.87 Million JPY | 30.47% |
| 2007 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| HEARTSEED INC | -1.44 Billion JPY | 1099.402% |
| Cawachi Limited | 11.85 Billion JPY | -22.123% |
| Pharmarise Holdings Corporation | 2.08 Billion JPY | -593.864% |
| Qol Holdings Co., Ltd. | 14.21 Billion JPY | -1.851% |
| MatsukiyoCocokara & Co. | 98.01 Billion JPY | 85.233% |
| Welcia Holdings Co., Ltd. | 67.62 Billion JPY | 78.597% |
| Create SD Holdings Co., Ltd. | 24.34 Billion JPY | 40.554% |
| NIHON CHOUZAI Co.,Ltd. | 14.65 Billion JPY | 1.235% |
| COSMOS Pharmaceutical Corporation | 51.42 Billion JPY | 71.855% |
| Tsuruha Holdings Inc. | 67.2 Billion JPY | 78.463% |
| Ohki Healthcare Holdings Co.,Ltd. | 3.81 Billion JPY | -279.298% |
| Satudora Holdings Co.,Ltd. | 2.71 Billion JPY | -433.702% |
| Kusuri No Aoki Holdings Co., Ltd. | 30.64 Billion JPY | 52.763% |
| Medical System Network Co., Ltd. | 6.99 Billion JPY | -106.89% |
| Shinnihonseiyaku Co., Ltd. | 4.18 Billion JPY | -245.606% |
| Sugi Holdings Co.,Ltd. | 50.74 Billion JPY | 71.476% |
| YAKUODO HOLDINGS Co., Ltd. | 8.16 Billion JPY | -77.312% |
| Astena Holdings Co., Ltd. | 4.17 Billion JPY | -246.913% |
| Ain Holdings Inc. | 31.22 Billion JPY | 53.642% |
| Sundrug Co.,Ltd. | 56.23 Billion JPY | 74.263% |